PetMed Express, Inc. is projected to rise to $2.32 by 2027, a +19% move from its current price of $1.96. PETS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.91 | $1.96 | $2.01 | -0.01% |
| Jul 14 | $1.89 | $1.96 | $2.03 | -0.03% |
| Jul 15 | $1.87 | $1.96 | $2.05 | -0.04% |
| Jul 16 | $1.86 | $1.96 | $2.06 | -0.06% |
| Jul 17 | $1.85 | $1.96 | $2.08 | -0.07% |
| Jul 18 | $1.84 | $1.96 | $2.09 | -0.09% |
| Jul 19 | $1.83 | $1.96 | $2.10 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.83 | $1.96 | $2.10 | -0.10% |
| Week 2 | $1.77 | $1.96 | $2.16 | -0.20% |
| Week 3 | $1.73 | $1.95 | $2.20 | -0.30% |
| Week 4 | $1.70 | $1.95 | $2.24 | -0.41% |
| Week 5 | $1.67 | $1.95 | $2.28 | -0.51% |
| Week 6 | $1.64 | $1.95 | $2.31 | -0.61% |
| Week 7 | $1.62 | $1.95 | $2.34 | -0.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PetMed Express, Inc. operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.
The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
PetMed Express, Inc. (PETS) is a pet-healthcare retailer operating in the United States. It is currently priced at $1.99 and has a market capitalization of $42.53M, with a rank of 4661.
The price outlook, based on the year-by-year forecast, shows a path from a neutral start in 2026 to a bullish trajectory through 2050, with rising average prices and sizable potential ROIs over time.
A major floor 27.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.3% below — buyers have tended to step in here.
The nearest ceiling, 12.2% above — a clean break opens room to run.
A major ceiling 39.8% above — clearing it would confirm fresh momentum.
Key PETS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PETS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.96 | Sell | $1.96 | Buy |
| MA 10 | $1.93 | Buy | $1.93 | Buy |
| MA 20 | $1.87 | Buy | $1.92 | Buy |
| MA 50 | $2.03 | Sell | $2.02 | Sell |
| MA 100 | $2.26 | Sell | $2.22 | Sell |
| MA 200 | $2.49 | Sell | $2.54 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.68 | Neutral |
| Stoch RSI (14) | 82.64 | Sell |
| CCI (20) | 82.23 | Neutral |
| Williams %R (14) | -16.67 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 7.10 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 83.33 | Sell |
| TRIX (15) | -0.29 | Sell |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 58.59 | Neutral |
| Momentum (10) | 0.19 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 1.97 | Sell |
| ADX (14) | 17.71 | Neutral |
| ATR (14) | 0.04 | Info |
Technical sentiment is NEUTRAL with an RSI of 60. The 50-day simple moving average (SMA50) is $2.07 and the 200-day simple moving average (SMA200) is $2.52, outlining a near-term range around the current level. Support is identified at $1.68 and resistance at $2.23. The 30-day price range spans from $1.64 to $2.42, reflecting limited near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.68 | $1.96 | $2.62 | 0% | Neutral | |
| $1.86 | $2.32 | $3.07 | +19% | Neutral | |
| $2.19 | $2.82 | $3.86 | +44% | Bullish | |
| $2.09 | $2.75 | $3.88 | +40% | Bullish | |
| $2.06 | $2.77 | $3.99 | +41% | Bullish | |
| $2.19 | $2.99 | $4.40 | +52% | Bullish | |
| $2.04 | $2.82 | $4.24 | +44% | Bullish | |
| $2.34 | $3.30 | $5.03 | +68% | Bullish | |
| $2.77 | $3.96 | $6.14 | +102% | Bullish | |
| $2.72 | $3.95 | $6.21 | +101% | Bullish | |
| $3.50 | $5.40 | $9.02 | +176% | Bullish | |
| $4.87 | $8.39 | $15.30 | +328% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.68 | $1.96 | $2.37 | +0.00% |
| August 2026 | $1.69 | $1.99 | $2.40 | +1.40% |
| September 2026 | $1.63 | $1.93 | $2.37 | -2.68% |
| October 2026 | $1.66 | $1.98 | $2.44 | +2.41% |
| November 2026 | $1.73 | $2.08 | $2.59 | +4.97% |
| December 2026 | $1.74 | $2.09 | $2.62 | +0.73% |
Click any year to see its month-by-month PETS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PETS is projected to trade between $1.68 and $2.62, averaging $1.96 — a potential gain of 0% from today's $1.96. A consolidation phase looks the most probable path here.
PetMed Express, Inc.'s 2027 outlook centres on $2.32, within a $1.86 to $3.07 range. That is up +19% on the projected 2026 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2028, PETS could reach as high as $3.86, with a base case around $2.82 and support toward $2.19 — roughly +44% from $1.96. Buyers look set to stay in control over this stretch.
Expect PETS to range from $2.09 to $3.88 through 2029. The $2.75 average target implies a +40% move from current prices. That is -2% versus the projected 2028 average. Momentum favours further upside here.
The PETS price prediction for 2030 points to an average of $2.77 (low $2.06, high $3.99) — a potential gain of +41% on today's $1.96. Buyers look set to stay in control over this stretch.
In 2031, PETS is projected to trade between $2.19 and $4.40, averaging $2.99 — a potential gain of +52% from today's $1.96. That is up +8% on the projected 2030 average. Momentum favours further upside here.
PetMed Express, Inc.'s 2032 outlook centres on $2.82, within a $2.04 to $4.24 range. That is -5% versus the projected 2031 average. That marks a +44% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PETS could reach as high as $5.03, with a base case around $3.30 and support toward $2.34 — roughly +68% from $1.96. Momentum favours further upside here.
Expect PETS to range from $2.77 to $6.14 through 2034. The $3.96 average target implies a +102% move from current prices. That is up +20% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PETS price prediction for 2035 points to an average of $3.95 (low $2.72, high $6.21) — a potential gain of +101% on today's $1.96. Momentum favours further upside here.
In 2040, PETS is projected to trade between $3.50 and $9.02, averaging $5.40 — a potential gain of +176% from today's $1.96. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
PetMed Express, Inc.'s 2050 outlook centres on $8.39, within a $4.87 to $15.30 range. That is up +55% on the projected 2040 average. That marks a +328% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PETS today (≈ 510.204082 PETS) could be worth
$4,282.44
+$3,282.44 (+328%) by 2050 · US Dollar
Based on the average projected PETS price of $8.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PETSwould be worth at today's price.
$1,000 invested in PETS on Jul 10, 2025 (≈ 293.255125 PETS) would be worth
$574.78
-$425.22 (-42.5%) today · 0.57× · US Dollar
Based on a PETS entry price of $3.41 vs. today's $1.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.98 | $989.9 | -1.0% |
| 1 month ago | $1.72 | $1,139.53 | +14.0% |
| 3 months ago | $2.3 | $852.17 | -14.8% |
| 6 months ago | $3.37 | $581.6 | -41.8% |
| 1 year ago | $3.41 | $574.78 | -42.5% |
| All time (5.0y) ago | $29.88 | $65.6 | -93.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PETS forecast.
Our base-case forecast reaches $3.90 around 2034.
Implied market cap at $3.90: $83.35M
The multi-year forecast shows a bullish trajectory, with successive years delivering higher average prices and rising ROIs. In 2026 the avg is $1.99 with ROI 0 and sentiment Neutral. By 2030 the avg rises to $2.80 with ROI 40.8 and sentiment Bullish.
The forecast continues to imply upside with 2040 the avg at $5.31 and ROI 167, and 2050 the avg at $8.03 with ROI 303.4. Max prices in these years also point to meaningful upside, with 2034 at $6.37 and 2040 at $9.20, and 2050 at $15.27. This suggests a long-run bullish path, though the estimates are not guarantees and carry inherent uncertainty.
Investors should weigh the upside potential against the risks and variability inherent in forward-looking forecasts.
Tap a question to reveal the answer.
2030 avg $2.80; min $2.05; max $4.14; ROI 40.8; sentiment BULLISH.
Forecasts indicate a bullish price path with rising averages and ROIs over time; for example 2040 avg $5.31 with ROI 167 and 2050 avg $8.03 with ROI 303.4. Note that 2026 shows ROI 0 and 2027 shows ROI 19, indicating variability and uncertainty.
2040 max is $9.20 and 2050 max is $15.27, indicating that reaching $10 or more is possible by 2050 according to the forecast.
Current price is $1.99 and market cap is $42.53M.
2026 min $1.68, avg $1.99, max $2.68; ROI 0; sentiment NEUTRAL.
PetMed Express, Inc. Community Discussion
0Share your PetMed Express, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.